The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
HSCS · Healthcare · No moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
HCIL · Healthcare · No moat
Doesn't clear the bar
The balanceSheet component abstained: Insufficient leverage/coverage inputs to score the balance sheet. The other four 20% weights were renormalized over the scored 80%.
| Measure | HSCS | HCIL | LAB | QUCY |
|---|---|---|---|---|
| Moat Score (0–100) | 35 (highest) | 35 (highest) | 35 (highest) | 35 (highest) |
| Methodology version | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 |
| Business trend | 20 | 43 (highest) | 20 | 20 |
| Pricing power | 68 | 53 | 76 | 94 (highest) |
| Returns on capital | — | 0 (highest) | 0 (highest) | 0 (highest) |
| Balance-sheet safety | 28 | — | 55 (highest) | 28 |
| Capital discipline | 24 | 44 (highest) | 24 | 33 |
| Price vs. high estimate | No price data | No price data | No price data | No price data |
| Market cap | $2.9M | — | $328.4M | $11.3M |
| Moat tier | No moat | No moat | No moat | No moat |
| Filings as of | FY2025 | FY2025 | FY2025 | FY2025 |